Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
Cancer Immunology Research
|
December 6, 2018
Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function
Paul E Clavijo, Jay Friedman, Yvette Robbins, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
June 1, 1992
[Molecular epidemiology of Salmonella enterica poisoning: correlation of the serotype and protein profile and plasmid DNA analysis]
A Mariscal Larrubia, E Clavijo Frutos, M Carnero Varo, et al.
Molecular Carcinogenesis
|
November 30, 2018
Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer
Rita Das, Jamie Coupar, Paul E Clavijo, et al.
Oncoimmunology
|
October 25, 2019
Enhancing direct cytotoxicity and response to immune checkpoint blockade following ionizing radiation with Wee1 kinase inhibition
Priya Patel, Lily Sun, Yvette Robbins, et al.
Cancer Research
|
April 2, 2017
Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ
Ruth J Davis, Ellen C Moore, Paul E Clavijo, et al.
Revista Clinica Espanola
|
June 1, 1992
[Evaluation of the incidence of nephrotoxicity associated with the use of aminoglycosides in patients with extrahepatic biliary obstruction]
E Márquez, M I Lucena, R J Andrade, et al.
Scientific Reports
|
March 8, 2019
Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay
V Saludes, A Antuori, B Reinhardt, et al.
Oncoimmunology
|
October 6, 2018
WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy
Lillian Sun, Ellen Moore, Rose Berman, et al.
Oncotarget
|
September 17, 2017
Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells
Paul E Clavijo, Ellen C Moore, Jianhong Chen, et al.
The Journal of Antimicrobial Chemotherapy
|
October 21, 2015
Clinical, virological and phylogenetic characterization of a multiresistant HIV-1 strain outbreak in naive patients in southern Spain
I Viciana, C M González-Domenech, R Palacios, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
Cancer Immunology Research
|
December 6, 2018
Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function
Paul E Clavijo, Jay Friedman, Yvette Robbins, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
June 1, 1992
[Molecular epidemiology of Salmonella enterica poisoning: correlation of the serotype and protein profile and plasmid DNA analysis]
A Mariscal Larrubia, E Clavijo Frutos, M Carnero Varo, et al.
Molecular Carcinogenesis
|
November 30, 2018
Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer
Rita Das, Jamie Coupar, Paul E Clavijo, et al.
Oncoimmunology
|
October 25, 2019
Enhancing direct cytotoxicity and response to immune checkpoint blockade following ionizing radiation with Wee1 kinase inhibition
Priya Patel, Lily Sun, Yvette Robbins, et al.
Cancer Research
|
April 2, 2017
Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ
Ruth J Davis, Ellen C Moore, Paul E Clavijo, et al.
Revista Clinica Espanola
|
June 1, 1992
[Evaluation of the incidence of nephrotoxicity associated with the use of aminoglycosides in patients with extrahepatic biliary obstruction]
E Márquez, M I Lucena, R J Andrade, et al.
Scientific Reports
|
March 8, 2019
Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay
V Saludes, A Antuori, B Reinhardt, et al.
Oncoimmunology
|
October 6, 2018
WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy
Lillian Sun, Ellen Moore, Rose Berman, et al.
Oncotarget
|
September 17, 2017
Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells
Paul E Clavijo, Ellen C Moore, Jianhong Chen, et al.
The Journal of Antimicrobial Chemotherapy
|
October 21, 2015
Clinical, virological and phylogenetic characterization of a multiresistant HIV-1 strain outbreak in naive patients in southern Spain
I Viciana, C M González-Domenech, R Palacios, et al.
Page
of 6